Natco Pharma shares jump after Supreme Court allows sale of Spinal Muscular Atrophy treatment drug

The Supreme Court, during its hearing said that there is no reason to interfere with the interim order issued by the Delhi High Court and subsequently refused to restrain Natco Pharma from the sale and export of the generic version of the Risdipalm.